Table 2.
Low | Mid-level | High | |||||
---|---|---|---|---|---|---|---|
Survey period | Positive/Total sampled | Prevalence,% | Positive/Total sampled | Prevalence, % | Positive/Total sampled | Prevalence, % | Total, n (%) |
21 Oct.-6 Nov.2008 | 16/1003 | 1.59 | 2/353 | 0.57 | 2/2060 | 0.97 | 20 (11.36) |
20 Jan.-4 Feb.2009 | 6/928 | 0.65 | 2/348 | 0.57 | 3/1929 | 0.15 | 11 (6.25) |
19 Jun.- 5 Jul.2009 | 16/951 | 1.68 | 8/339 | 2.36 | 3/1937 | 0.15 | 27 (15.34) |
18 Oct.-11 Nov.2009 | 43/924 | 4.76 | 8/345 | 2.32 | 20/1941 | 1.03 | 71 (40.34) |
27 Jan.-9 Feb.2010 | 21/920 | 2.28 | 6/317 | 1.89 | 7/1890 | 0.37 | 34 (19.32) |
5 Jun. -17 Jun. 2010 | 4/822 | 0.49 | 2/338 | 0.59 | 7/1862 | 0.37 | 13 (7.39) |
Total | 106/5548 | 1.91 | 28/2040 | 1.37 | 42/11619 | 0.36 | 176 (100)* |
*Two mixed infections of Plasmodium falciparum and Plasmodium vivax were not included